The Business Research Company’s global market reports are now updated with the latest market sizing information for the year 2023 and forecasted to 2032

The Business Research Company’s assisted reproductive technology market report forecasts the assisted reproductive technology market size to grow to $75.64 Billion by 2027, with a CAGR (compound annual growth rate) of more than 19%.

Learn More On The Assisted Reproductive Technology Market Report 2023 – https://www.thebusinessresearchcompany.com/report/assisted-reproductive-technology-global-market-report

Assisted Reproductive Technology Market Size Forecast
The global assisted reproductive technology market is expected to grow from $31.4 billion in 2022 to $37.56 billion in 2023 at a compound annual growth rate (CAGR) of 19.6%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The assisted reproductive technology market size is expected to grow to $75.64 billion in 2027 at a CAGR of 19.1%.

Europe held the largest assisted reproductive technology market share.

Key Assisted Reproductive Technology Market Driver ­– Rise In Number Of Infertility Cases
For instance, according to the UCLA Health, a US based health system, in 2020 around 15% of couples in the world have trouble in conceiving. Infertile couples are increasingly turning to assisted reproductive technology (ART), which is growing at a rate of 5% to 10% every year. Therefore, the rising number of infertility cases drives the growth of the assisted reproductive technology market.

Request for A Sample Of The Global Assisted Reproductive Technology Market Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=5489&type=smp

Key Assisted Reproductive Technology Market Trend – Technological Advancement
Major companies operating in the assisted reproductive technology are focused on developing technological
solutions to strengthen their position. For instance, in November 2020, NIPD Genetics, a Cyprus based biotechnology company launched Amfira PGT based on Target Capture Enrichment Technology. Amfira PGT is a preimplantation genetic test which can be employed during fertility treatment to improve the odds of becoming pregnant and giving birth to a healthy child. Amfira PGT can be used in In Vitro Fertilization (IVF) cycles to determine whether embryos are chromosomally normal (euploid) and have the best chance of culminating in a safe pregnancy and birth.

Assisted Reproductive Technology Market Segment
1) By Diagnosis: Ovulation Testing, Hysterosalpingography, Ovarian Reserve Testing, Genetic Testing
2) By Procedure Type: Fresh Non-Donor, Fresh Donor, Frozen Donor, Frozen Non-Donor, Embryo Or Egg Banking
3) By End-User: Hospitals, Fertility Clinics, Other End-Users

Assisted Reproductive Technology Market Major Players and Strategies
Major players in the assisted reproductive technology market are Cooper Surgical Inc., Ferring B.V., Hamilton Thorne Ltd., Merck KGaA, Genea Limited, California Cryobank, European Sperm Bank, OvaScience Inc., Bloom IVF Centre, Vitrolife, FUJIFILM Irvine Scientific Inc., Nidacon International AB, Monash IVF Group Ltd., Cook Medical, INVO Bioscience Inc., Thermo Fisher Scientific, Boston Science Corporation, Anecova, Carolinas Fertility Institute, Microm Ltd.

In August 2021, Virtus Health Limited, an Australia-based company offering assisted reproductive technology acquired Adora Fertility and three-day hospitals from Healius Limited for $45.0 million. This acquisition will help Virtus health to strengthen its portfolio for in-vitro fertilization (IVF). Adora Fertility is an Australia-based company that provide assisted reproductive technology (ART) including IVF (In-vitro fertilisation) and ICSI (Intracytoplasmic Sperm Injection).

The Assisted Reproductive Technology Global Market Report 2023 covers regional data on assisted reproductive technology market size, assisted reproductive technology market trends and drivers, opportunities, strategies, and assisted reproductive technology market competitor analysis. The countries covered in the assisted reproductive technology market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, the UK, and the USA, and the major seven regions are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa.

Assisted reproductive technology is based on the surgical removal of eggs from women’s ovaries and then fusing them with men’s sperm in the laboratory to create embryos. These embryos are then inserted back into the woman’s body. ART uses donor eggs, donor sperm, or previously stored frozen embryos. Assisted reproductive technology (ART) is used for the treatment of infertility in either eggs or embryos.

View More Reports Related To The Assisted Reproductive Technology Market –
Fertility Services Global Market Report 2023
Technology Advisory Global Market Report 2023
Fertility Drugs Global Market Report 2023

Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]

Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on: